Jim Cramer 建议谨慎使用 Mobileye Global，并在阿尔茨海默病试验中更倾向于 Eli Lilly 而不是 Cassava Sciences。 Jim Cramer advises caution on Mobileye Global and favors Eli Lilly over Cassava Sciences in Alzheimer's trials.
在“Mad Money”节目中，主持人 Jim Cramer 在闪电回合中谈到了股票查询。 On "Mad Money," host Jim Cramer addressed stock inquiries during a lightning round. 他指出，虽然 Cassava Sciences 正在进行阿尔茨海默氏症试验，但礼来的配方被认为更优越。 He noted that while Cassava Sciences is engaged in an Alzheimer's trial, Eli Lilly's formulation is viewed as superior. Cramer 建议对 Mobileye Global 持谨慎态度，并表示由于不确定性，他会避免投资。 Cramer advised caution regarding Mobileye Global, stating he would avoid investing due to uncertainty.